Novartis may spin off generic unit Sandoz to maximise value - NewsBreak

Oct 26 (Reuters) - Novartis (NOVN.S) has raised the prospect of divesting its generic drugs unit Sandoz after years of revamping the business, saying on Tuesday it would pursue whatever option would deliver most value for shareholders. "Novartis has commenced a strategic review of the Sandoz Division," the Swiss-based group...